Grants and Contributions:

Back to search

Title:

Anaerobic Assay Development of Proteobiotics

Agreement Number:

903230

Agreement Value:

$50,000.00

Agreement Date:

Mar 12, 2018 - Aug 13, 2018

Description:

MicroSintesis is a new biotechnology company specializing in the science of proteobiotics, bio-active metabolites produced by probiotics. Using proprietary fermentation and strain selection techniques, we are creating a new generation of scientifically advanced probiotics._x000D_ _x000D_ With this project, MicroSintesis will expand the commercial application for our technology and evaluate the efficacy of proteobiotics to impact the ability of the anaerobic pathogen, Clostridium perfringens, to cause infection in poultry. To do this, we will develop the anaerobic assays and production methods to support the pathogen's growth/testing with the goal of creating a new platform of products effective against anaerobic pathogens._x000D_ _x000D_

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Oakville, Ontario, CA L6J 1E1

Reference Number:

172-2018-2019-Q1-903230

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

843481516

Recipient Type:

For-profit organization

Recipient's Operating Name:

MicroSintesis Inc.

Recipient's Legal Name:

MicroSintesis Inc.

Federal Riding Name:

Oakville

Federal Riding Number:

35072

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

325410